2Nabelshima K,Komada N,Kishii J.TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant(L-10) of human rectal adenocarcinoma cell line RCM-1[J].Int J Cancer,1993,55:947-981
4Sui G,Soohoo C,Affarel B,et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells[J].Proc Natl Acad Sci USA,2002,99:5515-5520
5Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in culture mammalian cells[J].Nature,2001,411:494-498
6Pebernard S,Iggo RD.Determinants of interferon-stimulated gene induction by RNAi vectors[J].Differentiation,2004,72:103-111
7Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in culture mammalian cells[J].Nature,2001,411:494-498
8Sun J,Hemler ME.Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions[J].Cancer Res,2001,61 (3):2276-2281
9Davidson B,Goldberg I,Berner A,et al.EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma[J].Clin Exp Metastasis,2003,20(2):161-169
10Muramatsu T,Miyauchi T.Basigin (CD147):a multifunctional transmembrane protein involved in reproduction,neural function,inflammation and tumor invasion[J].Histol Histopathol,2003,18(3):981-987
3Piccart M J, Bertelsen K, James K, et al. Randomized intergroup trial of cisplatin-paclitaxe versus cisplafin - cyclophosphamide in women with advanced epithelial ovarian cancer: three- year results [J]. J Natl Cancer Inst, 2000, 92: 699-708.
4McGuire WP, Hoskins W J, Brady MF, et al. Cyclophosphamide and cisplatln compare with paclitaxel and cisplatin in patients with stage Ⅲ and stage IV ovarian cancer [J]. N Engl J Med, 1996, 334: 1-6.
5Ozols RF. Future directions in the treatment of ovarian cancer[J]. Semin Oncol, 2002, 29 (Suppl): 32-42.
6Bolis G, Scarfone G, Polverino G, et al. Paclitaxel 175 or 225 mg permeters squared with carbop latin in advanced ovarian cancer: a randomized triM[J]. Clin Oncol, 2004, 22 (4): 686.
7Lambert HE, Rustin G J, Gregogy WM, et al. A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian cancer[J]. Ann Oncol, 1997, 8: 327-333.
8Pan QW,Henry SD,Scholte BJ,et al.New therapeutic opportunities for hepatitis C based on small RNA[J].World J Gastroenterol,2007,13(33):4431.
9Prabhu R,Garry RF,Dash S.Small interfering RNA targeted to stem-loop II of the 5′untranslated region effectively inhibits expression of six HCV genotypes[J].Virol J,2006,3(1):100.
10Ilves H,Kaspar RL,Wang Q,et al.Inhibition of hepatitis C IRES-mediated gene expression by small hairpin RNAs in human hepatocytes and mice[J].Ann N Y Acad Sci,2006,1082:52.
